We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$414M
AUM Growth
+$142M
Cap. Flow
+$137M
Cap. Flow %
33.08%
Top 10 Hldgs %
55.2%
Holding
74
New
15
Increased
11
Reduced
28
Closed
14

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$7.74M
2
UNH icon
UnitedHealth
UNH
+$7.22M
3
PFE icon
Pfizer
PFE
+$6.28M
4
THC icon
Tenet Healthcare
THC
+$3.92M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$3.28M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$7.06M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.08M
3
VTRS icon
Viatris
VTRS
+$4.25M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$4.14M
5
BIIB icon
Biogen
BIIB
+$3.55M

Sector Composition

Rank Sector Weight
1 Healthcare 58.08%
2 Energy 0.72%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
26
Sanofi
SNY
$104B
$4.33M 1.05%
100,000
-30,000
-23% -$1.28M
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.31M 1.04%
25,000
-5,000
-17% -$865K
SRPT icon
28
Sarepta Therapeutics
SRPT
$1.81B
$4.18M 1.01%
27,500
+12,500
+83% +$1.52M
AZN icon
29
AstraZeneca
AZN
$251B
$4.13M 1%
50,000
-25,000
-33% -$1.96M
ISRG icon
30
Intuitive Surgical
ISRG
$139B
$3.93M 0.95%
22,500
-7,500
-25% -$1.29M
INCY icon
31
Incyte
INCY
$24.6B
$3.82M 0.92%
45,000
-15,000
-25% -$1.2M
BHC icon
32
Bausch Health
BHC
$2.37B
$3.53M 0.85%
140,000
-60,000
-30% -$1.42M
THC icon
33
Tenet Healthcare
THC
$20.9B
$3.51M 0.85%
+170,000
New +$3.92M
NBIX icon
34
Neurocrine Biosciences
NBIX
$16.8B
$3.38M 0.82%
+40,000
New +$3.28M
A icon
35
Agilent Technologies
A
$42B
$3.36M 0.81%
45,000
– –
XRAY icon
36
Dentsply Sirona
XRAY
$2.32B
$3.21M 0.78%
55,000
– –
CHRS icon
37
Coherus Oncology
CHRS
$192M
$3.2M 0.77%
145,000
-80,000
-36% -$1.39M
SAGE
38
DELISTED
Sage Therapeutics
SAGE
$3.2M 0.77%
17,500
+7,500
+75% +$1.28M
BLUE
39
DELISTED
bluebird bio
BLUE
$3.18M 0.77%
1,930
+563
+41% +$974K
CNC icon
40
Centene
CNC
$32.9B
$3.16M 0.76%
60,300
-19,700
-25% -$1.06M
SYK icon
41
Stryker
SYK
$133B
$3.08M 0.75%
15,000
-15,000
-50% -$2.86M
DGX icon
42
Quest Diagnostics
DGX
$26.2B
$3.05M 0.74%
+30,000
New +$2.88M
BMRN icon
43
BioMarin Pharmaceuticals
BMRN
$13.3B
$3M 0.72%
35,000
-10,000
-22% -$855K
LHCG
44
DELISTED
LHC Group LLC
LHCG
$2.99M 0.72%
25,000
-10,000
-29% -$1.13M
MDT icon
45
Medtronic
MDT
$114B
$2.92M 0.71%
+30,000
New +$2.74M
BPMC
46
DELISTED
Blueprint Medicines
BPMC
$2.83M 0.68%
30,000
+5,000
+20% +$413K
AMED
47
DELISTED
Amedisys
AMED
$2.43M 0.59%
20,000
– –
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
$2.42M 0.59%
35,000
+25,000
+250% +$1.75M
IQV icon
49
IQVIA
IQV
$39.8B
$2.41M 0.58%
+15,000
New +$2.1M
EXAS
50
DELISTED
Exact Sciences
EXAS
$2.36M 0.57%
+20,000
New +$2.02M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q2 2019 Portfolio in Review

As of Q2 2019, Sivik Global Healthcare held 74 positions worth $414M, up 52% from $271M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sivik Global Healthcare deployed $137M of net new capital in Q2 2019, opening 15 new positions and adding to 11 existing holdings. Its largest new stake was Becton Dickinson: 33,313 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 93% a quarter earlier, followed by Energy and Utilities.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $4.14M trimmed.

  • Sivik Global Healthcare's largest Q2 2019 buy was Becton Dickinson: 33,313 shares worth $8.19M.
  • Sivik Global Healthcare added most to Edwards Lifesciences in Q2 2019, an estimated $2.72M increase.
  • Sivik Global Healthcare's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $4.14M.
  • Sivik Global Healthcare fully exited Novo Nordisk in Q2 2019, selling an estimated $7.06M.
  • Sivik Global Healthcare's ten largest holdings make up 55% of its $414M portfolio in Q2 2019.
  • Sivik Global Healthcare opened 15 new positions and closed 14 in Q2 2019.
  • Sivik Global Healthcare's portfolio value rose 52% quarter-over-quarter to $414M.

Based on Sivik Global Healthcare's 13F filing for Q2 2019, filed 14 Aug 2019.